Obesity and cardiovascular disease
The prevalence of obesity has increased worldwide over the past few decades. In 2013, the
prevalence of obesity exceeded the 50% of the adult population in some countries from …
prevalence of obesity exceeded the 50% of the adult population in some countries from …
Uric acid and cardiovascular disease
G Ndrepepa - Clinica chimica acta, 2018 - Elsevier
Uric acid (UA) is an end product of purine metabolism in humans and great apes. UA acts as
an antioxidant and it accounts for 50% of the total antioxidant capacity of biological fluids in …
an antioxidant and it accounts for 50% of the total antioxidant capacity of biological fluids in …
Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
JB Funcke, PE Scherer - Journal of lipid research, 2019 - ASBMB
The breakthrough discoveries of leptin and adiponectin more than two decades ago led to a
widespread recognition of adipose tissue as an endocrine organ. Many more adipose tissue …
widespread recognition of adipose tissue as an endocrine organ. Many more adipose tissue …
Obesity, diabetes, and cardiovascular diseases: a compendium
PE Scherer, JA Hill - Circulation research, 2016 - Am Heart Assoc
1704 Circulation Research May 27, 2016 of epigenetic mechanisms contributing to
macrovascular disease in diabetes. The authors highlight the recent identification of …
macrovascular disease in diabetes. The authors highlight the recent identification of …
[HTML][HTML] The biology of urate
RT Keenan - Seminars in arthritis and rheumatism, 2020 - Elsevier
Urate is the end-product of the purine metabolism in humans. The dominant source of urate
is endogenous purines and the remainder comes through diet. Approximately two thirds of …
is endogenous purines and the remainder comes through diet. Approximately two thirds of …
Metabolically healthy obesity across the life course: epidemiology, determinants, and implications
CM Phillips - Annals of the New York Academy of Sciences, 2017 - Wiley Online Library
In recent years, different subphenotypes of obesity have been described, including
metabolically healthy obesity (MHO), in which a proportion of obese individuals, despite …
metabolically healthy obesity (MHO), in which a proportion of obese individuals, despite …
The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality
D Gustafsson, R Unwin - BMC nephrology, 2013 - Springer
Uric acid is the end product of purine metabolism in humans. High levels are causative in
gout and urolithiasis. Hyperuricaemia has also been implicated in the pathophysiology of …
gout and urolithiasis. Hyperuricaemia has also been implicated in the pathophysiology of …
Defining metabolically healthy obesity in children: a scoping review
S Damanhoury, AS Newton, M Rashid… - Obesity …, 2018 - Wiley Online Library
We conducted a scoping review to identify definitions of metabolically healthy obesity
(MHO), describe gaps in the literature, and establish a universal definition of MHO in …
(MHO), describe gaps in the literature, and establish a universal definition of MHO in …
Metabolically healthy obesity from childhood to adulthood—does weight status alone matter?
S Blüher, P Schwarz - Metabolism, 2014 - Elsevier
Up to 30% of obese people do not display the “typical” metabolic obesity-associated
complications. For this group of patients, the term “metabolically healthy obese (MHO)” has …
complications. For this group of patients, the term “metabolically healthy obese (MHO)” has …
Children with metabolically healthy obesity: a review
Children with “metabolically healthy obesity”(MHO) are a distinct subgroup of youth with
obesity, who are less prone to the clustering of cardiometabolic risk factors. Although this …
obesity, who are less prone to the clustering of cardiometabolic risk factors. Although this …